SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Doti AI raises $7M Seed round to help enterprises securely access and utilize internal data

Greylock appoints Mor Chen as partner to lead Israeli investments

Full list of Israeli high-tech funding rounds in 2025

Eleos doubles in value as it raises $60 million to disrupt behavioral healthcare

Buzz

Most popular

Daily

Weekly

1

Sam Altman-backed Apex Security in advanced talks to be acquired by Varonis for up to $40M

2

"Everyone will be a manager" - what the world of work will look like with AI agents

3

Facial recognition firm Oosto, formerly AnyVision, sold for $125M after raising $352M

4

Gong signs $8.45 million lease as it expands its R&D center in Ramat Gan

5

What went wrong at AnyVision? Lessons from a $352M flameout

Rimsa

3 stories about Rimsa

Israeli court documents reveal worrying details on Teva’s decision to acquire Mexico’s Rimsa

08.06.20|Sophie Shulman

Classified documents show that Teva's board of directors didn't even dedicate a full meeting to the acquisition

מטה חברת טבע תרופות

Derivative Suit Sheds Light on Teva’s Disastrous Rimsa Acquisition

28.05.19|Hezi Sternlicht

Teva acquired Mexican drugmaker Rimsa in 2016, but an anonymous email sent a week after the deal’s completion led Teva to launch an internal investigation—and sue the sellers for fraud

Teva and Rimsa Settle Contested $2.3-Billion Acquisition Deal Out of Court

10.04.18|Dror Reich

Teva acquired the Mexican plant in 2016 but shut it down immediately, citing discrepancies between Rimsa's regulatory filing and the actual assets, and filed a suit against the former owners